Released Mar 8, 2018, after the close
10-K filed Mar 8, 2018, 67 days after period end · 0001162194-18-000032
Q4 2017 · 10-K
Revenue$27.75M$27.75M +10.6% vs Q4 2016+12.1% vs Q3 2017
Net Income-$10.46M-$10.46M derivedN/M vs Q4 2016N/M vs Q3 2017
EPS Diluted-$0.27-$0.27 N/M vs Q4 2016N/M vs Q3 2017
Operating Incomederived-$8,735,000N/M
Operating Cash Flowderived$661,000N/M
Free Cash Flowderived$483,000N/M
Margins · derived
Operating margin-31.5%+39.1 pt vs Q4 2016
Net margin-37.7%+32.9 pt vs Q4 2016
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Revenue | $27.75M | $25.08M | $30.72M | $33.49M |
| Net Income | -$10.46M | -$17.70M | -$12.88M | -$10.94M |
| EPS Diluted | -$0.27 | -$0.61 | -$0.45 | -$0.39 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Standard Biotools Inc. · CIK 1162194 · Engraved from SEC EDGAR